Overview
Morphoceuticals target native bioelectrical and biochemical pathways to develop novel therapies that access core aspects of our biological operating system. Building on our success in regenerating functioning limbs using topical administration of ion channel modulators, we aim to achieve transformative therapeutic outcomes by leveraging computational control of our bioelectric programming and triggering developmental pathways that are too complex to micromanage.